dd-20201231.htm

Document


			DuPont de Nemours, Inc.			EXHIBIT 21
			SUBSIDIARIES OF THE REGISTRANT

Set forth below are certain subsidiaries of DuPont de Nemours, Inc.


			Organized Under Laws Of
Name
CUPOSIT Electronic Materials Zhangjiagang Co., Ltd.			China
DACI Investments, LLC			Delaware
DDP Speciality Products India Private Limited			India
DDP Specialty Electronic Materials US 5, LLC			Delaware
DDP Specialty Electronic Materials US 9, LLC			Delaware
DDP Specialty Electronic Materials US,LLC			Delaware
DDP Specialty Products Japan KK			Japan
DDP Specialty Products Korea Ltd.			Korea
DDP Specialty Products Taiwan Co, Ltd.			Taiwan
Dow Chemical OLED Ltd.			Korea
Dow Specialties Limited			Saudi Arabia
DSP S.A.S.			France
Du Pont (Korea) Inc			Korea
Du Pont (U.K.) Ltd.			United Kingdom
Du Pont Apollo (Shenzhen) Limited			China
Du Pont China Holding Company Ltd.			China
Du Pont China Limited			Hong Kong
Du Pont de Nemours (Belgium) BVBA			Belgium
Du Pont Products S.A.			Switzerland
DuPont (China) Research & Development and Management Co., Ltd.			China
DuPont (U.K.) Industrial Limited			United Kingdom
DuPont Beteiligungs GmbH			Austria
DuPont de Nemours (Deutschland) GmbH			Germany
DuPont de Nemours (Luxembourg) SARL			Luxembourg
DuPont de Nemours (Nederland) B.V.			The Netherlands
DuPont de Nemours International Sarl			Switzerland
DuPont de Nemours, Inc.			Delaware
DuPont Deutschland Holding GmbH & Co. KG			Germany
DuPont Deutschland Real Estate GmbH			Germany
DuPont E&I Holding, Inc.			Delaware
DuPont Electronic Polymers, LP			Delaware
DuPont Electronics Microcircuits Industries, Ltd.			Bermuda
DuPont Electronics, Inc.			Delaware
DuPont Filaments - Americas, LLC			Delaware
DuPont Industrial Biosciences USA, LLC			Delaware
DuPont International (Luxembourg) SCA			Luxembourg
DuPont Kabushiki Kaisha			Japan
DuPont KGA B.V.			The Netherlands
DuPont Performance Specialty Products (Thailand) Limited			Thailand
DuPont Polymers, Inc.			Delaware
DuPont Safety & Construction, Inc.			Delaware
DuPont Science (Luxembourg) SARL			Luxembourg
DuPont Service Co B.V., Hoek, Grand-Saconnex Branch			Switzerland
DuPont SP Services Sarl			Switzerland
DuPont Specialty Products Kabushiki Kaisha			Japan
DuPont Specialty Products Operations Sàrl			Switzerland
DuPont Specialty Products USA, LLC			Delaware
DuPont Stylo Corporation			Japan


DuPont Taiwan Limited			Taiwan
DuPont Teijin Films China Ltd.			Hong Kong
DuPont Toray Specialty Materials Kabushiki Kaisha			Japan
DuPont Trading (Shanghai) Co., Ltd.			China
DuPont Uentrop GmbH			Germany
DuPont Xingda Filaments Company Limited			China
E&C EMEA Holding 2 B.V.			The Netherlands
E. I. DuPont Canada - Thetford Inc.			Canada
EIDCA Specialty Products Company			Canada
EKC Technology, Inc.			California
Electronic Materials DuPont (Dongguan) Ltd.			China
FilmTec Corporation			Delaware
inge GmbH			Germany
MECS Inc.			Delaware
Multibase S.A.			France
Nitta Haas Incorporated			Japan
Nitta Haas Trading Company			Japan
Nova Scotia Company			Canada
OMEX Overseas Holdings Inc.			Virgin Islands
Performance Speciality Products do Brasil			Brazil
Performance Specialty Products (India) Private Limited			India
Performance Specialty Products (Singapore) Pte. Ltd.			Singapore
Performance Specialty Products Asturias S.L.U.			Spain
Performance Specialty Products France SAS			France
Performance Specialty Products Iberica S.L.U.			Spain
Performance Specialty Products NA, LLC			Delaware
PP EMEA Holding 1 B.V.			The Netherlands
PP EMEA Holding 3 B.V.			The Netherlands
Productos Especializados de México DDM, S. de R.L. de C.V.			Mexico
Refining Technology Solutions, LLC			Delaware
Rodel Particles, Inc			Japan
Rohm and Haas Asia Holdings B.V.			The Netherlands
Rohm and Haas Denmark Bermuda Holding Company ApS			Denmark
Rohm and Haas Electronic Materials (Shanghai) Ltd.			China
Rohm and Haas Electronic Materials Asia Limited			Hong Kong
Rohm and Haas Electronic Materials Asia-Pacific Co., Ltd.			Taiwan
Rohm and Haas Electronic Materials CMP Asia Inc.			Delaware
Rohm and Haas Electronic Materials CMP Holdings, Inc.			Delaware
Rohm and Haas Electronic Materials CMP, LLC			Delaware
Rohm and Haas Electronic Materials CMP Korea Ltd.			Korea
Rohm and Haas Electronic Materials CMP Taiwan			Taiwan
Rohm and Haas Electronic Materials K.K.			Japan
Rohm and Haas Electronic Materials Korea Ltd.			Korea
Rohm and Haas Electronic Materials LLC			Delaware
Rohm and Haas Electronic Materials Singapore Pte. Ltd.			Singapore
Rohm and Haas HK Dongguan Holding Limited			Hong Kong
Shenzhen DuPont Agriscience Investment Co., Ltd.			China
Shenzhen DuPont Performance Materials Investment Co., Ltd.			China
SP EMEA Holding 7 B.V.			The Netherlands
SP EMEA Holding 8 B.V.			The Netherlands
SP Holding IB, Inc.			Delaware
SP International Holding 1 B.V.			The Netherlands
Specialty Electronic Materials Italy S.R.L.			Italy
Specialty Electronic Materials Netherlands B.V.			The Netherlands
Specialty Electronic Materials Switzerland GmbH			Switzerland


Specialty Electronic Materials UK Limited			United Kingdom
Specialty Products DPP, Inc.			Delaware
Specialty Products Netherlands Holding 4 BV			The Netherlands
Specialty Products Turkey Endustri Urunleri Limited Sirketi			Turkey
Zhejiang OMEX Environmental Engineering Corporate			China

Set forth below are Nutrition & Biosciences, Inc., (a wholly owned subsidiary of DuPont at 12/31/20), and its subsidiaries:


			Organized Under Laws Of
Name
Nutrition & Biosciences, Inc.			Delaware
Danisco (China) Co. Ltda.			China
Danisco (China) Holding Co. Ltd.			China
Danisco (India) Private Limited			India
Danisco Argentina S.A.			Argentina
Danisco Australia Pty Limited			Australia
Danisco Brasil Ltda.			Brazil
Danisco Chile S.A.			Chile
Danisco Czech Republic, a.s.			Czech Republic
Danisco Deutschland GmbH			Germany
Danisco France SAS			France
Danisco Holding USA Inc.			Delaware
Danisco Japan Limited			Japan
Danisco Malaysia Sdn. Bhd.			Malaysia
Danisco Mexicana S.A. de C.V			Mexico
Danisco Singapore Pte. Ltd.			Singapore
Danisco Sweeteners Oy			Finland
Danisco Switzerland AG			Switzerland
Danisco UK Ltd.			United Kingdom
Danisco US Inc.			Delaware
Danisco USA Inc.			Missouri
DDP Specialty Products Germany GmBH & Co. KG			Germany
DSP Germany N&B Real Estate GmbH & Co KG			Germany
DuPont LA Holding I B.V.			The Netherlands
Dupont Nutrition (Thailand) Ltd.			Thailand
DuPont Nutrition and Biosciences Iberica S.L.U.			Spain
DuPont Nutrition Biosciences ApS			Denmark
DuPont Nutrition Food Ingredients (Beijing) Co., Ltd			China
DuPont Nutrition Ireland			Ireland
Dupont Nutrition Norge AS			Norway
DuPont Nutrition Philippines, Inc.			Philippines
DuPont Nutrition USA, Inc.			Delaware
Finnfeeds Finland Oy			Finland
Finnfeeds Oy			Finland
Genencor (China) Bio-Products Co., Ltd.			China
Genencor International OY			Finland
Genencor International, B.V.			The Netherlands
Genencor International, BVBA			Belgium
N&B EMEA Holding B.V.			The Netherlands
N&B Services B.V.			The Netherlands
N&H EMEA Holding B.V.			The Netherlands
Nutrition & Bioscience (Switzerland) GmbH			Switzerland
Nutrition & Biosciences (UK) Ltd			United Kingdom
Nutrition & Biosciences USA 1, LLC.			Delaware
Nutrition & Biosciences USA 4, Inc.			Delaware


Rohm and Haas Wood Treatment LLC			Delaware
Solae L.L.C.			Delaware
SP Nutrition & Health (Singapore), Inc.			Delaware
Specialty Products N&H, Inc.			Delaware
Specialty Products US, LLC			Delaware
ZAO Danisco			Russia

Subsidiaries not listed would not, if considered in the aggregate as a single subsidiary, constitute a significant subsidiary.

Document


			Consent of Independent Registered Public Accounting Firm			EXHIBIT 23.1

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-227202) and Form S-8 (No. 333-240242, 333-231864, 333-220330, 333-220324) of DuPont de Nemours, Inc. of our report dated February 12, 2021 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.


/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 12, 2021

Document


			Consent of Independent Registered Public Accounting Firm			EXHIBIT 23.2

We consent to the incorporation by reference of our report dated February 11, 2019 (February 14, 2020 as to changes to the 2018 financial statements as a result of a change in method of accounting for inventory, a change in reportable segments, and the effects of discontinued operations, common control transactions, and a reverse stock split.) relating to the consolidated financial statements of DuPont de Nemours, Inc. and subsidiaries, appearing in this Annual Report on Form 10-K of DuPont de Nemours, Inc. for the year ended December 31, 2020, in the following Registration Statements of DuPont de Nemours, Inc.

Form S-3:

No.

333-227202

Form S-8:

Nos.

333-240242

333-231864

333-220330

333-220324


/s/ DELOITTE & TOUCHE LLP
Midland, Michigan
February 12, 2021

Document


			Consent of Independent Registered Public Accounting Firm			EXHIBIT 23.3

We consent to the incorporation by reference in Registration Statement No. 333-227202 on Form S-3 and Registration Statement Nos. 333-240242, 333-231864, 333-220330, and 333-220324 on Form S-8 of our report dated February 14, 2020, relating to the financial statements of The Dow Chemical Company (not presented herein), appearing in this Annual Report on Form 10-K of DuPont de Nemours, Inc. for the year ended December 31, 2020.


/s/ DELOITTE & TOUCHE LLP
Midland, Michigan
February 12, 2021

Document


			Consent of Independent Registered Public Accounting Firm			EXHIBIT 23.4

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-227202) and Form S-8 (No. 333-240242, 333-231864, 333-220330, 333-220324) of DuPont de Nemours, Inc. of our report dated February 11, 2021 relating to the financial statements and financial statement schedule of E. I. du Pont de Nemours and Company, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

February 12, 2021

Document

DuPont de Nemours, Inc.

EXHIBIT 31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Edward D. Breen, certify that:

1. I have reviewed this annual report on Form 10-K of DuPont de Nemours, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 12, 2021


/s/ Edward D. Breen
Edward D. Breen
Chief Executive Officer

Document

DuPont de Nemours, Inc.

EXHIBIT 31.2

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Lori Koch, certify that:

1.I have reviewed this annual report on Form 10-K of DuPont de Nemours, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 12, 2021


/s/ Lori Koch
Lori Koch
Chief Financial Officer

Document

DuPont de Nemours, Inc.

EXHIBIT 32.1

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Edward D. Breen, Chief Executive Officer of DuPont de Nemours, Inc. (the “Company”), certify that:

1.the Annual Report on Form 10-K of the Company for the year ended December 31, 2020 as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Edward D. Breen
Edward D. Breen
Chief Executive Officer
February 12, 2021

Document

DuPont de Nemours, Inc.

EXHIBIT 32.2

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Lori Koch, Chief Financial Officer of DuPont de Nemours, Inc. (the “Company”), certify that:

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Lori Koch
Lori Koch
Chief Financial Officer
February 12, 2021

dd-20201231.xsd
Attachment: XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT

dd-20201231_cal.xml
Attachment: XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT

dd-20201231_def.xml
Attachment: XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT

dd-20201231_lab.xml
Attachment: XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT

dd-20201231_pre.xml
Attachment: XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT